Meta Information
ID:kpv
Name:
Schema Version:2.4_uniform_evidence_2026_06_18
Created
2026-05-25T02:00:00Z
Model
wave15-peptide-schema-migration
Interactions
Target id:
/condition/pregnancy
Target name:
Pregnancy
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Reproductive toxicology data incomplete.
Actionable advice:
KPV is best avoided during pregnancy until more safety data are available.
Validation status:
unvalidatable
Evidence tier:
tier_e
Evidence basis:
unvalidatable
Evidence anchors:
Source url:
Scientific literature support not found
Exact phrase from label:
Label source:
Peptide Biologix Research Monograph: KPV
Action type:
avoid
Target id:
/condition/lactation
Target name:
Lactation
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Lack of lactation transfer data.
Actionable advice:
KPV is best avoided while breastfeeding.
Validation status:
unvalidatable
Evidence tier:
tier_e
Evidence basis:
unvalidatable
Evidence anchors:
Source url:
Scientific literature support not found
Exact phrase from label:
Label source:
Peptide Biologix Research Monograph: KPV
Action type:
avoid
Target id:
/condition/active-cancer
Target name:
Active Cancer
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Immunomodulatory effects of unclear consequence in active malignancy.
Actionable advice:
If you have active cancer, talk to your oncologist before using KPV.
Validation status:
unvalidatable
Evidence tier:
tier_e
Evidence basis:
unvalidatable
Evidence anchors:
Source url:
Scientific literature support not found
Exact phrase from label:
Label source:
Peptide Biologix Research Monograph: KPV
Action type:
informational_none
Target id:
/condition/severe-immunodeficiency
Target name:
Severe Immunodeficiency
Severity:
moderate
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Immunomodulatory effects in already compromised immune systems.
Actionable advice:
If you have a severe immune deficiency, consult a specialist before using KPV.
Validation status:
unvalidatable
Evidence tier:
tier_e
Evidence basis:
unvalidatable
Evidence anchors:
Source url:
Scientific literature support not found
Exact phrase from label:
Label source:
Peptide Biologix Research Monograph: KPV
Action type:
informational_none
Target id:
/class/bioactive-peptides
Target name:
Peptide Therapeutics
Severity:
minor
Interaction type:
adverse
Nature:
absolute
Temporal spacing:
Hours before target:
0
Hours after target:
0
Description:
Rapid metabolism to naturally occurring amino acids; limited systemic exposure.
Actionable advice:
No specific drug interactions are known, but consult your clinician before combining therapies.
Validation status:
unvalidatable
Evidence tier:
tier_e
Evidence basis:
unvalidatable
Evidence anchors:
Source url:
Scientific literature support not found
Exact phrase from label:
Label source:
Peptide Biologix Research Monograph: KPV
Action type:
informational_none